Topical Therapy for Actinic Keratoses, II: Diclofenac, Colchicine, and Retinoids

Mr. Tutrone, Ms. Saini, Ms. Caglar, and Dr. Crespo report no conflict of interest. Dr. Weinberg has been a clinical investigator for 3M Pharmaceuticals. The authors report discussion of off-label use of imiquimod, colchicine, and tretinoin. Mr. Tutrone and Ms. Caglar are medical students at the University of Vermont, Burlington. Ms. Saini is a medical student at New York University, New York. Dr. Weinberg is Assistant Clinical Professor of Dermatology at Columbia University College of Physicians and Surgeons, New York, New York. Dr. Crespo is in private practice in Brattleboro, Vermont.

William D. Tutrone, BS; Ritu Saini, BA; Selin Caglar, BA; Jeffrey M. Weinberg, MD; Jorge Crespo, MD

Accepted for publication March 6, 2003. Mr. Tutrone and Ms. Caglar are medical students at the University of Vermont, Burlington. Ms. Saini is a medical student at New York University, New York. Dr. Weinberg is Assistant Clinical Professor of Dermatology at Columbia University College of Physicians and Surgeons, New York, New York. Dr. Crespo is in private practice in Brattleboro, Vermont.